Biotech company Vertex Pharmaceuticals (NASDAQ: VRTX) has made for a solid investment over the past decade, more than quadrupling in value during that period. The stock generated fantastic returns for ...
Vertex Pharmaceuticals (NASDAQ: VRTX) has brought in billions of dollars in earnings over time thanks to its leadership in the market for cystic fibrosis (CF) treatment. And along with partner CRISPR ...
Zacks Investment Research on MSN
Vertex Pharmaceuticals Incorporated (VRTX) is a trending stock: Facts to know before betting on it
Vertex Pharmaceuticals (VRTX) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
Craig Hallum analyst Eric Stine raised his price target on Vertex Energy to $25 from $13 and affirmed a buy rating after the company unveiled an asset-sale plan. Vertex Energy (VTNR) shares on ...
Vertex Pharmaceuticals (NASDAQ: VRTX) climbed as much as 32% from the start of the year through the middle of last month. The company was on a roll when it came to good news. Its cystic fibrosis (CF) ...
ThinkEquity Partners applauded the recent deal announced between Vertex Pharmaceuticals and healthcare giant Johnson & Johnson , saying the collaboration to develop and market experimental hepatitis C ...
Vertex Pharmaceuticals VRTX secured permission from the FDA to initiate a rolling biologics license application (BLA) submission for its ex-vivo gene-therapy exagamglogene autotemcel (exa-cel). The ...
Any drugmaker knows that no matter what a drug's sticker price, its sales can only go as far as its patient pool will take it. So for Vertex ($VRTX), whose cystic ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Orum Therapeutics, which has ...
BOSTON--(BUSINESS WIRE)--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that Michel Lagarde has been appointed to its Board of Directors as an independent director. Mr. Lagarde is ...
The Vertex Company has been awarded a potential seven-year, $850 million contract to help a U.S. Navy aviation component maintain aircraft for the branch’s test and evaluation activities. The company ...
Vertex Pharmaceuticals is a leader in cystic fibrosis treatments. The company is working on expanding its business, which will open up more growth opportunities. Its strong financials equip the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results